Kilitch Drugs (India) on Monday informed the exchanges that its unit Kilitch Estro Biotech Plc has acquired land for setting up a pharma plant in Ethiopia. The Bureau of Rural Land and Environmental Protection, Federal Democratic Republic of Ethiopia, has allotted 4,317.5 square metres of land on lease for a period of 45 years. The land is located near the highway with three-phase electricity passing through it. Kilitch undertakes contract manufacturing for over 20 pharmaceutical companies, including Sandoz India, Zydus Cadila and Nicholas Piramal India, among others. Shares of Kilitch Drugs gained 20 per cent at ₹40.40 on the NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.